Adjuvant galantamine to risperidone improves negative and cognitive symptoms in a patient presenting with schizophrenialike psychosis after traumatic brain injury.
Bennouna
Mehdi
M
Greene
Valerie B
VB
Defranoux
Luc
L
D000328:Adult; D014150:Antipsychotic Agents / Q000627:therapeutic use*; D020201:Brain Hemorrhage, Traumatic / Q000150:complications* / Q000523:psychology*; D002800:Cholinesterase Inhibitors / Q000627:therapeutic use*; D003072:Cognition Disorders / Q000188:drug therapy* / Q000209:etiology / Q000523:psychology; D005260:Female; D005702:Galantamine / Q000627:therapeutic use*; D006801:Humans; D011569:Psychiatric Status Rating Scales; D011618:Psychotic Disorders / Q000209:etiology* / Q000523:psychology*; D018967:Risperidone / Q000627:therapeutic use*; D012565:Schizophrenic Psychology
D014150:Antipsychotic Agents; D002800:Cholinesterase Inhibitors; D005702:Galantamine; D018967:Risperidone